Free Trial
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

$0.95
-0.04 (-4.04%)
(As of 06/21/2024 ET)
Today's Range
$0.92
$1.00
50-Day Range
$0.85
$1.48
52-Week Range
$0.70
$4.14
Volume
88,932 shs
Average Volume
76,922 shs
Market Capitalization
$8.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BTCY stock logo

About Biotricity Stock (OTCMKTS:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

BTCY Stock News Headlines

Do you think trading w/emotion helps?
Holding onto our losers too long and cutting our winners at the first sign of profit. Steven recognized that the only way to really solve this problem was to build an automated trading bot using a machine that has zero emotion.
Biotricity Inc BTCY
Biotricity's Earnings Outlook
Do you think trading w/emotion helps?
Holding onto our losers too long and cutting our winners at the first sign of profit. Steven recognized that the only way to really solve this problem was to build an automated trading bot using a machine that has zero emotion.
Biotricity reports Q2 results
Earnings Outlook For Biotricity
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2023
Today
6/22/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

Net Income
$-18,660,000.00
Net Margins
-163.11%
Pretax Margin
-163.11%

Debt

Sales & Book Value

Annual Sales
$11.63 million
Book Value
($2.67) per share

Miscellaneous

Free Float
6,963,000
Market Cap
$8.95 million
Optionable
Not Optionable
Beta
1.40
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 39)
    Founder, President, CEO & Chairman
    Comp: $732k
  • Mr. S. John Ayanoglou (Age 57)
    Chief Financial Officer
    Comp: $305.75k
  • Mr. Andy Wong
    Vice President of Operations
  • Dr. George N. Nikopoulos
    Director of Business Development
  • Mr. Matt Zabel
    Vice President of Sales & Strategy
  • Mr. Amir Ali
    Chief Development Officer

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed in 2024?

Biotricity's stock was trading at $1.15 on January 1st, 2024. Since then, BTCY shares have decreased by 17.4% and is now trading at $0.95.
View the best growth stocks for 2024 here
.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) issued its quarterly earnings results on Tuesday, February, 14th. The company reported ($0.54) EPS for the quarter, hitting analysts' consensus estimates of ($0.54). The business had revenue of $2.46 million for the quarter, compared to the consensus estimate of $2.80 million.

When did Biotricity's stock split?

Shares of Biotricity reverse split before market open on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCY) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners